Next Generation Sequencing System - NovaSeq 6000 - BIOMEDIC JSC

Home

Products & Applications

Early detection

Early diagnosis of cancer

Next Generation Sequencing System – NovaSeq 6000

Certificate

Brand

Illumina

Product Type

Instrument

Highlights

Scalable platform; Flexible performance & Streamlined operation

Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time

Application

– Large Whole-Genome Sequencing (human, plant, animal)
– Small Whole-Genome Sequencing (microbe, virus)
– Exome Sequencing
– Targeted Gene Sequencing (amplicon, gene panel)
– RNA sequencing
– Methylation sequencing
– Shotgun Metagenomics

Specifications

		Flow cell
		SP	S1	S2	S4
Output data	2 × 50 bp	65–80 Gb	134–167 Gb	333–417 Gb	N/A
	2 × 100 bp	N/A	266–333 Gb	667–833 Gb	1600–2000 Gb
	2 × 150 bp	200–250 Gb	400–500 Gb	1000–1250 Gb	2400–3000 Gb
Quality of Q30	2 × 50 bp	≥ 85%
	2 × 100 bp	≥ 80%
	2 × 150 bp	≥ 75%
Running time	2 × 50 bp	~13 hr	~13 hr	~16 hr	N/A
	2 × 100 bp	N/A	~19 hr	~25 hr	~36 hr
	2 × 150 bp	~25 hr	~25 hr	~36 hr	~44 hr

Details: https://sapac.illumina.com/systems/sequencing-platforms/novaseq.html

Other information

Supplier

Illumina

Related Products

EntroGen NGS Targeted Hotspot Panel

The EntroGen NGS Targeted Hotspot Panel is a comprehensive assay that detects clinically relevant mutations in solid tumors using next-generation sequencing, compatible with fresh frozen and FFPE samples. It offers high sensitivity, low DNA input, and the ability to batch up to 12 samples in a single run, making it ideal for labs with limited sample volumes.

EntroGen’s BRCA Complete™ Expanded Panel

EntroGen’s BRCA Complete™ Expanded Panel is a comprehensive NGS solution that detects both germline and somatic mutations in genes like BRCA1, BRCA2, CHEK2, PALB2, RAD51C, and TP53 with high sensitivity and specificity. Compatible with blood, fresh frozen, and FFPE samples, the panel reduces allele dropouts and off-target reads using a tiled amplicon PCR approach. It includes reagents for library preparation and user-friendly software for easy mutation identification, along with quality control assays to ensure high-quality data without repeat sequencing.

NgeneBio – SOLIDaccuTest™

SOLIDaccuTest™ is an excellent tool for discovering variants associated with solid tumors using a comprehensive approach to next-generation sequencing (NGS). It reflects the latest research trends and is optimized for medical purposes by selecting essential genes of solid tumors including lung, colon, breast, skin brain, stomach and ovarian cancers, etc.

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ PLUS with CE-IVD certificate for HBOC Breast/Ovarian Cancer Test

Next-Generation Sequencing System – NextSeq 2000

The NextSeq 2000 Sequencing System uses patterned flow cells similar to those that power the NovaSeq™ 6000 System. The result is a highly flexible and scalable benchtop system that offers the highest cluster density flow cell of any on-market NGS system to date, driving down the cost per gigabase (Gb) of the sequencing run.

NextSeq 1000 sequencing system

Product Information

Model: NextSeq 1000

Manufacturer: Illumina

Origin: Singapore/United States

Launching year: 01/2020

PANARealTyperTM HPV Kit

PANA RealTyper^TMHPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

DxFLEX

DxFLEX is a new clinical flow cytometry platform derived from the successful CytoFLEX. The advanced sensitivity and intuitive software DxFLEX makes flow cytometry routine for both novice and expert flow cytometry technicians and promotes standardization. Functionality in the autoloader facilitates accurate results and sample tracking.